Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FLURAZEPAM vs FLURBIPROFEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FLURAZEPAM vs FLURBIPROFEN: Safety Overview

Metric FLURAZEPAM FLURBIPROFEN
Total FAERS Reports 976 647
Deaths Reported 94 27
Death Rate 9.6% 4.2%
Hospitalizations 509 292
Average Patient Age 49.5 yrs 38.4 yrs
% Female Patients 66.4% 82.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 1, 1997
Manufacturer Chartwell RX, LLC IPG Pharmaceuticals, Inc.
Route ORAL ORAL
Marketing Status Discontinued Discontinued